Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis

Authors: Simon T.J.; Roberts W.G.; Berlin R.G.; Hayden L.J.; Berman R.S.; Reagan J.E.

Source: Clinical Therapeutics, Volume 17, Number 6, November 1995 , pp. 1147-1156(10)

Publisher: Elsevier

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/0149-2918(95)80093-X

Affiliations: 1: Merck Research Laboratories, West Point, Pennsylvania, U.S.A.

Publication date: 1995-11-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Simon T.J. ;  Roberts W.G. ;  Berlin R.G. ;  Hayden L.J. ;  Berman R.S. ;  Reagan J.E.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers